Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma
Clinical trial NCT01939327 · COMPLETED
Trial details
- NCT number
- NCT01939327
- Sponsor
- Institut Paoli-Calmettes
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2017-10-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.